Statistics for Newron Pharmaceuticals S.p.A. (id:13166 NWRN)
Valuation metrics
Market cap
148.28M
Enterprise value
168.67M
Trailing P/E (ttm)
-9.33
Forward P/E
-110.14
PEG ratio
-110.14
Price/Sales (ttm)
21.27
Price/Book (mrq)
Enterprise Value/Revenue
26.04
Enterprise Value/EBITDA
-12.20
Overview
Shares outstanding
19.23M
Float
18.00M
Shares short
% Held by insiders
3.00%
% Held by institutions
3.00%
Average volume (10 days)
47.74K
Average volume (90 days)
Price summary
52-Week low
4.37
52-Week high
11.20
52-Week change
41.11%
Beta
3.00
50-Day moving average
7.78
200-Day moving average
8.25
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
December 31, 2023
Profitability
Profit margin
-270.17%
Operating margin
-225.51%
Operational effectiveness
Return on assets
-33.24%
Return on equity
54.25%
Income statement
Revenue (ttm)
3.00
Revenue per share (ttm)
3.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-13,822,593.00
Net income to common (ttm)
-17,498,706.00
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
11.33M
Total cash per share (mrq)
3.00
Total debt (mrq)
45.39M
Total Debt/Equity (mrq)
-1.52
Current ratio (mrq)
373.40%
Book value per share (mrq)
-1.62
Cash flow
Cash flow statement
-12,419,426.00
Levered free cash flow (LFCF)
-10,558,138.00